Clinical need vs technology push in innovation
SP-0664
Abstract
Clinical need vs technology push in innovation
1Iridium Network, Faculty of Medicine and Health Sciences, Antwerp University, Medical Physics, Antwerp, Belgium
Show Affiliations
Hide Affiliations
Abstract Text
As George Orwell once wrote: “the true genius is
to create a problem and then sell the solution.” The latter might offer a too
sarcastic view on developments in radiation oncology as indeed our discipline is
characterized by the synergy between increasing accuracy & precision in dose
delivery and improving knowledge in radiobiology. As such improvements can only be encouraged. However,
truth be said, one cannot ignore some bias created by enthusiasm, focusing on
innovation and neglecting clinical priorities, which brings to mind Monty
Python’s hospital sketch on the “machine that goes ping”. With this
presentation the author suggests a short “time-out”, stimulating a critical
review on some of the innovations that emerged the last decades in view of what
is important to our patients and what is an optimal balance within the current challenges
that we face in health care economics. Much like MLC’s were claimed a necessity
for IMRT a few decades ago; MRI-linacs are being introduced as a prerequisite
for real-time adaptive radiation therapy, arguments are being generated to boost
the advantages of proton beam therapy, real-time tumour tracking presented as
the ultimate motion management, FLASH as a game changer, and radiomics and AI
as the future of automation and decision making. One might argue that some decisions
supporting clinical introduction of novel technology are driven by a “me-too”
argumentation rather than clinical relevance. Developments must be multi-disciplinary in nature, process-oriented rather than device-oriented, risk- and evidence-based,
resource and risk optimised and flexible enough to cope with current and
anticipated changes in oncology and health care. The multi-disciplinary
radiation oncology community has an obligation to increase awareness and public
confidence that radiation therapy is the most cost-effective cancer treatment
(obviously, in optimal synergy with other cancer treatment modalities), and
also that it is one of the safest medical specialties. New technology that is
optimally implemented, appropriately applied and robustly assured will continue
to support both of these messages.